The Inflammation Network in the Pathogenesis of Erectile Dysfunction: Attractive Potential Therapeutic Targets
CURRENT PHARMACEUTICAL DESIGN, cilt.26, sa.32, ss.3955-3972, 2020 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 26 Sayı: 32
- Basım Tarihi: 2020
- Doi Numarası: 10.2174/1381612826666200424161018
- Dergi Adı: CURRENT PHARMACEUTICAL DESIGN
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Agricultural & Environmental Science Database, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.3955-3972
- Anahtar Kelimeler: Erectile dysfunction, endothelial dysfunction, metabolic disease, inflammation, cytokines, anti-inflammatory drugs, NITRIC-OXIDE SYNTHASE, NECROSIS-FACTOR-ALPHA, ENDOTHELIUM-DEPENDENT VASODILATATION, CARDIOVASCULAR RISK-FACTORS, RENIN-ANGIOTENSIN SYSTEM, CORONARY-ARTERY-DISEASE, CAVERNOUS NERVE INJURY, C-REACTIVE PROTEIN, TNF-ALPHA, METABOLIC SYNDROME
- Ankara Üniversitesi Adresli: Evet
Özet
Background: Erectile dysfunction (ED) is an evolving health problem in the aging male population. Chronic low-grade inflammation is a critical component of ED pathogenesis and a probable intermediate stage of endothelial dysfunction, especially in metabolic diseases, with the inclusion of obesity, metabolic syndrome. and diabetes.